JP2019519536A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019519536A5 JP2019519536A5 JP2018562626A JP2018562626A JP2019519536A5 JP 2019519536 A5 JP2019519536 A5 JP 2019519536A5 JP 2018562626 A JP2018562626 A JP 2018562626A JP 2018562626 A JP2018562626 A JP 2018562626A JP 2019519536 A5 JP2019519536 A5 JP 2019519536A5
- Authority
- JP
- Japan
- Prior art keywords
- gitr
- seq
- pharmaceutical composition
- sequence
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022000978A JP2022058518A (ja) | 2016-07-01 | 2022-01-06 | Ｇｉｔｒアゴニストおよびｃｐｇを用いた組み合わせ抗腫瘍療法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662357750P | 2016-07-01 | 2016-07-01 | |
| US62/357,750 | 2016-07-01 | ||
| PCT/US2017/040259 WO2018005950A1 (en) | 2016-07-01 | 2017-06-30 | Combined anti tumor therapy with a gitr agonist and cpg |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022000978A Division JP2022058518A (ja) | 2016-07-01 | 2022-01-06 | Ｇｉｔｒアゴニストおよびｃｐｇを用いた組み合わせ抗腫瘍療法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019519536A JP2019519536A (ja) | 2019-07-11 |
| JP2019519536A5 true JP2019519536A5 (https=) | 2020-07-27 |
Family
ID=59363240
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018562626A Pending JP2019519536A (ja) | 2016-07-01 | 2017-06-30 | Ｇｉｔｒアゴニストおよびｃｐｇを用いた組み合わせ抗腫瘍療法 |
| JP2022000978A Pending JP2022058518A (ja) | 2016-07-01 | 2022-01-06 | Ｇｉｔｒアゴニストおよびｃｐｇを用いた組み合わせ抗腫瘍療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022000978A Pending JP2022058518A (ja) | 2016-07-01 | 2022-01-06 | Ｇｉｔｒアゴニストおよびｃｐｇを用いた組み合わせ抗腫瘍療法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20190263919A1 (https=) |
| EP (1) | EP3478721A1 (https=) |
| JP (2) | JP2019519536A (https=) |
| CN (1) | CN109641967A (https=) |
| WO (1) | WO2018005950A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016297249B2 (en) * | 2015-07-23 | 2020-11-12 | Inhibrx Biosciences, Inc. | Multivalent and multispecific GITR-binding fusion proteins |
| RU2734432C1 (ru) | 2019-04-23 | 2020-10-16 | Закрытое Акционерное Общество "Биокад" | Моноклональное антитело, которое специфически связывается с GITR |
| CN111732658B (zh) * | 2020-06-28 | 2022-04-26 | 英诺湖医药(杭州)有限公司 | 一组gitr单克隆抗体及其医药用途 |
| WO2022036013A1 (en) * | 2020-08-11 | 2022-02-17 | Exicure Operating Company | Tumor necrosis factor receptor superfamily (tnfrsf) agonists, spherical nucleic acid (sna) tlr9 agonists and checkpoint inhibitors for antitumor therapy |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6713610B1 (en) | 1990-01-12 | 2004-03-30 | Raju Kucherlapati | Human antibodies derived from immunized xenomice |
| US6673986B1 (en) | 1990-01-12 | 2004-01-06 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5874299A (en) | 1990-08-29 | 1999-02-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5877397A (en) | 1990-08-29 | 1999-03-02 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US6300129B1 (en) | 1990-08-29 | 2001-10-09 | Genpharm International | Transgenic non-human animals for producing heterologous antibodies |
| US6255458B1 (en) | 1990-08-29 | 2001-07-03 | Genpharm International | High affinity human antibodies and human antibodies against digoxin |
| US6342220B1 (en) | 1997-08-25 | 2002-01-29 | Genentech, Inc. | Agonist antibodies |
| CA2348292A1 (en) | 1998-10-30 | 2000-05-11 | Takeda Chemical Industries, Ltd. | Betacellulin protein-containing preparation |
| US6900292B2 (en) | 2001-08-17 | 2005-05-31 | Lee-Hwei K. Sun | Fc fusion proteins of human erythropoietin with increased biological activities |
| JP4810427B2 (ja) | 2003-05-22 | 2011-11-09 | アボット・ラボラトリーズ | インダゾール、ベンズイソオキサゾールおよびベンズイソチアゾールキナーゼ阻害剤 |
| EP1809671B1 (en) * | 2004-11-09 | 2014-07-16 | University Of Southern California | CpG/antibody conjugate against cancer |
| AU2006230099B2 (en) | 2005-03-25 | 2012-04-19 | Gitr, Inc. | GITR binding molecules and uses therefor |
| ES2776406T3 (es) | 2007-07-12 | 2020-07-30 | Gitr Inc | Terapias de combinación que emplean moléculas de enlazamiento a GITR |
| US7981415B2 (en) | 2007-09-07 | 2011-07-19 | Cisthera, Inc. | Humanized PAI-1 antibodies |
| EP2473531A4 (en) | 2009-09-03 | 2013-05-01 | Merck Sharp & Dohme | Anti-gitr antibodies |
| MX346912B (es) | 2009-12-07 | 2017-04-05 | Univ Leland Stanford Junior | Metodos para mejorar terapia con anticuerpos antitumor. |
| KR101566539B1 (ko) | 2012-06-08 | 2015-11-05 | 국립암센터 | 신규한 Ｔｈ2 세포 전환용 에피토프 및 이의 용도 |
| AR097306A1 (es) | 2013-08-20 | 2016-03-02 | Merck Sharp & Dohme | Modulación de la inmunidad tumoral |
| TW201605896A (zh) | 2013-08-30 | 2016-02-16 | 安美基股份有限公司 | Gitr抗原結合蛋白 |
| SG10201912986PA (en) | 2014-05-28 | 2020-02-27 | Agenus Inc | Anti-gitr antibodies and methods of use thereof |
| PT3151921T (pt) | 2014-06-06 | 2019-11-21 | Bristol Myers Squibb Co | Anticorpos contra recetor do fator de necrose tumoral induzido por glicocorticoide e utilizações dos mesmos |
| AU2016297249B2 (en) * | 2015-07-23 | 2020-11-12 | Inhibrx Biosciences, Inc. | Multivalent and multispecific GITR-binding fusion proteins |
| EP3365371B1 (en) | 2015-10-22 | 2025-10-08 | Ablynx NV | Gitr agonists |
| BR112018010172A2 (pt) | 2015-11-19 | 2018-11-21 | Bristol Myers Squibb Co | anticorpos contra receptor de fator de necrose de tumor induzido por glicocorticoide (gitr) e usos dos mesmos |
-
2017
- 2017-06-30 CN CN201780053872.6A patent/CN109641967A/zh active Pending
- 2017-06-30 EP EP17740540.4A patent/EP3478721A1/en not_active Withdrawn
- 2017-06-30 JP JP2018562626A patent/JP2019519536A/ja active Pending
- 2017-06-30 WO PCT/US2017/040259 patent/WO2018005950A1/en not_active Ceased
- 2017-06-30 US US16/310,725 patent/US20190263919A1/en not_active Abandoned
-
2022
- 2022-01-06 JP JP2022000978A patent/JP2022058518A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yin et al. | Strategies targeting PD-L1 expression and associated opportunities for cancer combination therapy | |
| JP2021058197A5 (https=) | ||
| Mishan et al. | CXCR4 and CCR7: Two eligible targets in targeted cancer therapy | |
| JP2016535009A5 (https=) | ||
| JP2019519536A5 (https=) | ||
| JP2012196206A5 (https=) | ||
| HRP20200383T1 (hr) | Ciljana vezna sredstva protiv b7-h1 | |
| JP2019508013A5 (https=) | ||
| RU2021130306A (ru) | Композиции il-12, нацеленные на edb | |
| JP2016527286A5 (https=) | ||
| JP2015534577A5 (https=) | ||
| JP2021521822A5 (https=) | ||
| JP2010531140A5 (https=) | ||
| JP2012102109A5 (https=) | ||
| JP2019203035A5 (https=) | ||
| JP2009505676A5 (https=) | ||
| JP2017521486A5 (https=) | ||
| JP2020517658A5 (https=) | ||
| JP2017507937A (ja) | ガン標的化ｉｌ−１２免疫療法 | |
| Rueda et al. | Targeting the chemokine receptor CXCR4 for cancer therapies | |
| EP3160497A1 (en) | Conjugates for immunotherapy | |
| BR112021008083A2 (pt) | terapia contra o câncer com célula imunológica anti-ptk7 | |
| JP2019506862A5 (https=) | ||
| JP2019519529A5 (https=) | ||
| JP2019531293A5 (https=) |